日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Insulinoma diagnosis and characterization with intratumoral heterogeneity employing [(18)F]FB(ePEG12)12-exendin-4 PET/MRI

利用[(18)F]FB(ePEG12)12-艾塞那肽-4 PET/MRI进行胰岛素瘤的诊断和表征,并分析其肿瘤内异质性。

Yoshida, Hayao; Murakami, Takaaki; Miyake, Kanae Kawai; Shimizu, Yoichi; Itagaki, Koji; Sakaki, Kentaro; Otani, Daisuke; Fujimoto, Hiroyuki; Yabe, Daisuke; Inagaki, Nobuya; Nakamoto, Yuji

Quantitative β-Cell Mass Imaging Redefines Disease Staging and Glycemic Control in Type 1 Diabetes

定量β细胞质量成像重新定义了1型糖尿病的疾病分期和血糖控制

Sakaki, Kentaro; Murakami, Takaaki; Yoshida, Hayao; Otani, Daisuke; Miyake, Kanae Kawai; Shimizu, Yoichi; Fujimoto, Hiroyuki; Yabe, Daisuke; Nakamoto, Yuji; Inagaki, Nobuya

Heterogeneous cardiovascular effects of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes: a causal forest and target trial emulation study

钠-葡萄糖协同转运蛋白2抑制剂对2型糖尿病患者心血管效应的异质性:一项因果森林和靶点试验模拟研究

Mori, Yuichiro; Komura, Toshiaki; Adomi, Motohiko; Yagi, Ryuichiro; Fukuma, Shingo; Kawakami, Koji; Kondo, Naoki; Tsugawa, Yusuke; Yabe, Daisuke; Yanagita, Motoko; Inoue, Kosuke

BALLAST study: A multicentre, open-label, randomized-controlled, 52-week clinical trial of the efficacy and safety of luseogliflozin in older Japanese adults with type 2 diabetes receiving leucine-enriched amino acid supplementation and physical exercise programme

BALLAST 研究:一项多中心、开放标签、随机对照、为期 52 周的临床试验,旨在评估卢格列净在接受富含亮氨酸氨基酸补充剂和体育锻炼计划的 2 型糖尿病老年日本患者中的疗效和安全性。

Takahashi, Yoshihiro; Hayashi, Makoto; Kato, Takehiro; Horikawa, Yukio; Tsunekawa, Shin; Kuwata, Hitoshi; Seino, Yutaka; Ogata, Ryota; Murotani, Kenta; Yabe, Daisuke

GLP-1 receptor agonists and cardiovascular outcomes in Asian, Black or African American, and White populations: An updated meta-analysis including the SOUL trial

GLP-1受体激动剂与亚洲人、黑人或非裔美国人以及白人人群的心血管结局:一项纳入SOUL试验的最新荟萃分析

Hasebe, Masashi; Su, Chen-Yang; Kamido, Hisashi; Yabe, Daisuke; Yoshiji, Satoshi

D-Allulose Reduces Weight More Persistently than Oral Semaglutide While Both Equally Elevate Grip Strength in Diet-Induced Obese Mice

D-阿洛酮糖比口服索马鲁肽更能持久地减轻体重,而两者在提高饮食诱导肥胖小鼠的握力方面效果相当。

Rakhat, Yermek; Banno, Seiya; Zhantleu, Dauren; Tsunekawa, Shin; Yabe, Daisuke; Seino, Yutaka; Iwasaki, Yusaku; Yada, Toshihiko

Circadian feeding promotion by Ninjin'yoeito counteracts frailty in aged mice

人间养荣汤促进昼夜节律性摄食,可对抗老年小鼠的虚弱症。

Wang, Lei; Rakhat, Yermek; Nakata, Masanori; Dezaki, Katsuya; Kuwata, Hitoshi; Zhang, Boyang; Han, Wanxin; Banno, Seiya; Abe, Chikara; Ogiso, Noboru; Sakurai, Takashi; Tsunekawa, Shin; Yabe, Daisuke; Iwasaki, Yusaku; Seino, Yutaka; Yada, Toshihiko

Endogenous GIP signaling is indispensable for DPP-4 inhibitor-mediated metabolic control in mice

内源性GIP信号通路对于小鼠DPP-4抑制剂介导的代谢调控至关重要。

Kubota-Okamoto, Saki; Kubota, Sodai; Tsuchida, Hiromi; Liu, Yanyan; Banno, Seiya; Imaizumi, Toshinori; Fujisawa, Taro; Takahashi, Yoshihiro; Kato, Takehiro; Horikawa, Yukio; Iizuka, Katsumi; Murakami, Takaaki; Fujiwara, Yuuka; Kuwata, Hitoshi; Yamazaki, Yuji; Seino, Yutaka; Tsunekawa, Shin; Yabe, Daisuke

Moderate-intensity statin plus ezetimibe as an alternative to high-intensity statin therapy

中等强度他汀类药物联合依折麦布可作为高强度他汀类药物治疗的替代方案

Yabe, Daisuke; Albawa’neh, Areej S; Ali, Bassam R

Insulin edema in slowly progressive type 1 diabetes: improvement following adjustment of insulin therapy

缓慢进展型 1 型糖尿病患者的胰岛素性水肿:调整胰岛素治疗后有所改善

Okamura, Emi; Harada, Norio; Okuno, Kana; Yamamoto, Kana; Murakami, Takaaki; Ueda, Yohei; Yabe, Daisuke